This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Abbott Laboratories Corporation. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Shailendra V Bordawekar: Innovator in Chemotherapeutic Development
Introduction
Shailendra V Bordawekar is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of chemotherapeutic agents. His work has the potential to impact the treatment of various diseases.
Latest Patents
Bordawekar holds a patent for a crystalline chemotherapeutic compound, specifically N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea Hydrate Crystalline Form 1. This patent includes methods for its synthesis, formulations that incorporate it, and therapeutic methods for treating patients with diseases using this compound.
Career Highlights
Throughout his career, Bordawekar has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories and AbbVie Bahamas Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Bordawekar has collaborated with esteemed colleagues such as Thomas B Borchardt and Alexander F Chu-Kung. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Shailendra V Bordawekar is a distinguished inventor whose work in chemotherapeutics showcases his commitment to advancing medical science. His contributions are vital for the ongoing development of effective treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile